Clinical Trials Directory

Trials / Terminated

TerminatedNCT03959072

Cardiac Cath Lab Staff Radiation Exposure

Cardiac Cath Lab Staff Radiation Exposure During Chronic Total Occlusion PCI: CorPath GRX vs. Manual

Status
Terminated
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Corindus Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

The objective of this randomized safety and observational study is to demonstrate CorPath GRX chronic total occlusion PCI is safe, and that Cardiac Catheterization Laboratory staff have no additional exposure to radiation when compared to conventional manual chronic total occlusion PCI procedures without added procedure time.

Detailed description

This is prospective, dual-arm, randomized, multi-center, observational study comparing patient outcomes and staff radiation exposure in chronic total occlusion PCI procedures through 48 hours post procedure or hospital discharge, whichever occurs first.

Conditions

Interventions

TypeNameDescription
DEVICERobotic CTO PCIRandomized to robotic CTO PCI.
PROCEDUREConventional (Manual) CTO PCIRandomized to manual CTO PCI.

Timeline

Start date
2019-09-05
Primary completion
2021-09-14
Completion
2021-09-15
First posted
2019-05-22
Last updated
2023-02-02

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03959072. Inclusion in this directory is not an endorsement.